Fonar has retained an investment banker to assess its MRI operations, the Melville, NY, company announced on March 3. While Fonar executives aren’t providing any details about the firm’s intentions, the company did say that it plans to make
Fonar has retained an investment banker to assess its MRI operations, the Melville, NY, company announced on March 3. While Fonar executives arent providing any details about the firms intentions, the company did say that it plans to make the investment community aware of the new MRI technologies amassed by Fonar from its recent heavy investment in R&D that are expected to enhance shareholder value.
Its unclear whether that awareness could translate into a divestiture of the MRI business. Fonar for the last several years has been attempting a comeback in MRI, but the vendor has been stymied by a lack of market interest in its new line of Quad scanners. For the companys most recent financial period, Fonar recorded only $602,000 in product sales (SCAN 3/3/99).
On the other hand, Fonar has been successful in making acquisitions to increase its healthcare services business, which has been the engine behind the firms revenue growth. The company said its retention of an investment banker will help the firm evaluate prospective acquisitions.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.